In 2025, ECDC celebrates 20 years of strengthening Europe’s defences against infectious diseases and protecting the health of over 500 million people across the EU.
A new ECDC survey reveals that 3.1% of the residents in long-term care facilities had at least one healthcare-associated infection at the time of the study.
ECDC commissions an annual External Quality Assessment (EQA) scheme for the serotyping and molecular-based cluster analysis of
Salmonella to monitor the typing methods used, data quality and comparability, and the capability of laboratories to perform these methods.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 June 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, West Nile virus, measles, autochthonous chikungunya virus, mass gathering monitoring (Jubilee of 2025 in Italy, Hajj – Kingdom of Saudi Arabia, EuroPride - Portugal, invasive pneumococcal disease, influenza A(H5N1), Risk Assessment under production.
This report presents a description of COVID-19 vaccine coverage in the European Union/European Economic Area (EU/EEA) between 1 August 2024 and 28 March 2025.
Join the ECDC Crowd and work on improving and transforming health science one task at a time with your insights on study design, statistical analysis, data collection and interpretation
About ECDC
ECDC collects, analyses and shares data on more than 50 infectious disease topics. ECDC experts assess risks to Europe and provide guidance to help countries prevent and respond to outbreaks and public health threats.
